Relative Fitness of Fluoroquinolone-resistantStreptococcus pneumoniae
Open Access
- 1 June 2005
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 11 (6), 814-820
- https://doi.org/10.3201/eid1106.040840
Abstract
Fluoroquinolone resistance in Streptococcus pneumoniae is primarily mediated by point mutations in the quinolone resistance–determining regions of gyrA and parC. Antimicrobial resistance mutations in housekeeping genes often decrease fitness of microorganisms. To investigate the fitness of quinolone-resistant S. pneumoniae (QRSP), the relative growth efficiencies of 2 isogenic QRSP double mutants were compared with that of their fluoroquinolone-susceptible parent, EF3030, by using murine nasopharyngeal colonization and pneumonia models. Strains containing the GyrA: Ser81Phe, ParC: Ser79Phe double mutations, which are frequently seen in clinical QRSP, competed poorly with EF3030 in competitive colonization or competitive lung infections. However, they efficiently produced lung infection even in the absence of EF3030. The strain containing the GyrA: Ser81Phe, ParC: Ser79Tyr double mutations, which is seen more frequently in laboratory-derived QRSP than in clinical QRSP, demonstrated reduced nasal colonization in competitive or noncompetitive lung infections. However, the strain was equally able to cause competitive or noncompetitive lung infections as well as EF3030.Keywords
This publication has 38 references indexed in Scilit:
- Quinolone Resistance among Pneumococci: Therapeutic and Diagnostic ImplicationsClinical Infectious Diseases, 2004
- Activities of Garenoxacin against Quinolone-Resistant Streptococcus pneumoniae Strains In Vitro and in a Mouse Pneumonia ModelAntimicrobial Agents and Chemotherapy, 2004
- Fluoroquinolone Resistance in Clinical Isolates ofStreptococcus pneumoniaefrom Asian Countries: ANSORP StudyMicrobial Drug Resistance, 2004
- Immunizations with Pneumococcal Surface Protein A and Pneumolysin Are Protective against Pneumonia in a Murine Model of Pulmonary Infection withStreptococcus pneumoniaeThe Journal of Infectious Diseases, 2003
- Cross-resistance, relatedness and allele analysis of fluoroquinolone-resistant US clinical isolates of Streptococcus pneumoniae (1998-2000)Journal of Antimicrobial Chemotherapy, 2003
- Molecular Epidemiology of Penicillin-Resistant and Ciprofloxacin-Resistant Streptococcus pneumoniae in CanadaAntimicrobial Agents and Chemotherapy, 2003
- Role of Pneumococcal Surface Protein C in Nasopharyngeal Carriage and Pneumonia and Its Ability To Elicit Protection against Carriage of Streptococcus pneumoniaeInfection and Immunity, 2002
- Genetic Analyses of Mutations Contributing to Fluoroquinolone Resistance in Clinical Isolates of Streptococcus pneumoniaeAntimicrobial Agents and Chemotherapy, 2001
- Streptococcus pneumoniae Isolates with Reduced Susceptibility to Ciprofloxacin in Spain: Clonal Diversity and Appearance of Ciprofloxacin-Resistant Epidemic ClonesAntimicrobial Agents and Chemotherapy, 2001
- A Nosocomial Outbreak of Fluoroquinolone‐ResistantStreptococcus pneumoniaeClinical Infectious Diseases, 2001